Cochlear Ltd ADR CHEOY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $49.12
- Day Range
- $51.00–51.42
- 52-Week Range
- $31.82–98.49
- Bid/Ask
- $24.05 / $79.30
- Shares Outstanding
- 130.80M
- Market Cap
- $6.72B
- Volume/Avg
- 14,688 / 22,266
Key Statistics
- Price/Earnings (Normalized)
- 29.51
- Price/Sales
- 4.23
- Dividend Yield (Trailing)
- 2.36%
- Dividend Yield (Forward)
- 2.36%
- Dividend Payment Schedule
- Apr, Oct
- Total Yield
- 2.36%
Company Profile
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2026, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,500
- Website
- https://www.cochlear.com
Competitors
Valuation
|
Metric
|
CHEOY
|
RMD
|
DEMANT
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.51 | 21.78 | 29.36 |
Price/Book Value | 5.61 | 5.41 | 6.74 |
Price/Sales | 4.23 | 6.28 | 3.08 |
Price/Cash Flow | 26.98 | 18.90 | 17.72 |
Price/Earnings
CHEOY
RMD
DEMANT
Financial Strength
|
Metric
|
CHEOY
|
RMD
|
DEMANT
|
|---|---|---|---|
Quick Ratio | 1.19 | 1.83 | 0.54 |
Current Ratio | 2.15 | 3.10 | 0.82 |
Interest Coverage | 16.43 | — | 6.70 |
Quick Ratio
CHEOY
RMD
DEMANT
Profitability
|
Metric
|
CHEOY
|
RMD
|
DEMANT
|
|---|---|---|---|
Return on Assets (Normalized) | 11.76% | 19.09% | 6.76% |
Return on Equity (Normalized) | 17.18% | 25.91% | 24.80% |
Return on Invested Capital (Normalized) | 15.41% | 22.30% | 9.75% |
Return on Assets
CHEOY
RMD
DEMANT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|Qp%!<^ | LOCK|kt@z | $179B | |||
| Medtronic PLC
MDT
| LOCK|CH$cG#> | LOCK|%w#y | $122B | |||
| Stryker Corp
SYK
| LOCK|s%c@x>%d | LOCK|$Fm | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|MpjPTF | LOCK|hQ%% | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|TNtv$<^ | LOCK|FnwN | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|W#Sh>& | LOCK|!@> | $32B | |||
| DexCom Inc
DXCM
| LOCK|X!X&Gc?> | LOCK|<>&F% | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|##@ | LOCK|D? | $26B | |||
| Steris PLC
STE
| LOCK|dzv&LS | LOCK|$X&C | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|jWRGLtR | LOCK|g! | $19B |
United States